Booster of the "More Time for Patients" Program

NCT ID: NCT06491797

Last Updated: 2024-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

764 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-01

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to determine if reactivating a hospital program called "Plus de temps au service des patients" (PTP) can improve the quality of pain management for patients and increase job satisfaction among healthcare professionals. The main questions this study aims to answer are:

* Does reactivating PTP improve the quality of pain management?
* Does reactivating PTP increase healthcare professionals' job satisfaction? In this study, researchers will compare the effects of reactivating the program immediately to reactivating it after a 3-month delay.

Participants in the trial are healthcare professionals who will:

* Select 2 or 3 elements of the program they believe would be most beneficial to reactivate in their hospital units.
* Implement the selected elements for 3 months.
* Complete job satisfaction and burnout questionnaires before and after the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Clinical Encounter Quality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Intervention group will see immediate reactivation of the program where control intervention will be the program as it is usually applied before the application of the booster measure (applied delayed by three months).
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Immediate reactivation

Our intervention will be booster measure of the existing PTP elements that will be designed for each unit that has been randomized to the immediate intervention group. The booster will consist in a reactivation through audit and feedback of 2-3 elements of the PTP program. The selection of the elements to boost will be done locally in each unit through a coordinated discussion between representants of the PTP organization and representants of the unit's medical and nursing professionals. This will create an adaptable intervention that will feature selected standards among the list of 36 existing standards. The boost will be performed over 3 months

Group Type EXPERIMENTAL

Immediate reactivation

Intervention Type BEHAVIORAL

Our intervention will be booster measure of the existing PTP elements that will be designed for each unit that has been randomized to the immediate intervention group. The booster will consist in a reactivation through audit and feedback of 2-3 elements of the PTP program. The selection of the elements to boost will be done locally in each unit through a coordinated discussion between representants of the PTP organization and representants of the unit's medical and nursing professionals. This will create an adaptable intervention that will feature selected standards among the list of 36 existing standards. The boost will be performed over 3 months

Delayed reactivation

The control intervention will also be PTP as applied usually, in the control group before the application of the booster measure (applied delayed by three months).

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Immediate reactivation

Our intervention will be booster measure of the existing PTP elements that will be designed for each unit that has been randomized to the immediate intervention group. The booster will consist in a reactivation through audit and feedback of 2-3 elements of the PTP program. The selection of the elements to boost will be done locally in each unit through a coordinated discussion between representants of the PTP organization and representants of the unit's medical and nursing professionals. This will create an adaptable intervention that will feature selected standards among the list of 36 existing standards. The boost will be performed over 3 months

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Implementation of PTP finished at least 6 months previously
* Agreement to the study from both medical head of service and head of unit (IRES)


* Healthcare professionals \>18 yo.
* Healthcare professionals working in a HUG service of medicine or surgery.
* Healthcare professionals include Physicians, Nurses, Assistant Nurses, Pharmacists, Physiotherapists and other physical therapists.
* Provided general informed consent.


* Patients hospitalised in one of the boosted units.
* Cognitive ability to provide satisfaction assessment.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Geneva

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas Agoritsas

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Agoritsas, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Geneva

Delphine S. Courvoisier, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Geneva

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geneva University Hospitals

Geneva, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thomas Agoritsas, MD, PhD

Role: CONTACT

0041 79 553 45 43

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thomas Agoritsas, MD,PhD

Role: primary

0041 79 553 45 43

Delphine S. Courvoisier, PhD

Role: backup

0041 79 553 11 41

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PTPBooster

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.